Funding boost in fight against leukaemia
Friday, July 4th, 2008Medical Research News University of Manchester researchers have been ...
Archive for the ‘Research News’ Category
Medical Research News University of Manchester researchers have been ...
Research sheds light on the molecular basis of SIDS
Friday, July 4th, 2008Medical Research News Sudden Infant Death Syndrome (SIDS) is ...
New computational tool to study complex clusters of genes
Friday, July 4th, 2008Medical Research News Two Texas A&M University researchers have ...
New understanding of how herpes simplex virus 1 hides during inactive phase
Friday, July 4th, 2008Medical Research News Now that Duke University Medical Center ...
Computational research hones cancer-fighting strategies
Friday, July 4th, 2008Medical Research News A Florida State University faculty member ...
New insight into role of statins in dementia
Friday, July 4th, 2008Medical Research News Cholesterol-lowering drugs known as statins have ...
PharmaLive: Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology
Friday, July 4th, 2008BIOCITECH, France, July 3/PRNewswire-FirstCall/ -- Cellectis SA today announced the signature of an agreement with Regeneron Pharmaceuticals, Inc. over the use of Cellectis' patents covering certain uses of homologous recombination for the generation of innovative human therapies, including the development of fully human monoclonal antibodies. As part of the agreement, ...
PharmaLive: RegeneRx Completes Enrollment and Dosing of Phase IA Safety Trial for Potential Heart Drug
Thursday, July 3rd, 2008BETHESDA, Md.--(BUSINESS WIRE)--Jul 3, 2008 - REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it has completed enrollment and dosing of 40 healthy subjects for its Phase IA clinical trial testing RGN-352, an injectable formulation of TB4 for potential use in treating acute myocardial infarction patients (AMI or heart attack). ...
PharmaLive: PerkinElmer Establishes ViaCord Research Institute to Further Cord Blood Stem Cell Advancements
Thursday, July 3rd, 2008WALTHAM, Mass.--(BUSINESS WIRE)--Jul 3, 2008 - PerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research Institute(TM) (VRI(TM)) aimed at investigating new potential future uses of umbilical cord blood-derived stem cells. Led by a team of leading scientists and physicians, VRI will ...
PharmaLive: Patheon Reaches Agreement with BSP Pharmaceuticals for Development and Manufacture of Cytotoxics
Thursday, July 3rd, 2008TORONTO, July 2, 2008 /CNW/ - Patheon (TSX:PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, has completed a shareholders agreement and a sales and marketing agreement with Italy's BSP Pharmaceuticals, a company focussed on the development and manufacturing of cytotoxic pharmaceutical products. Under the terms of ...
PharmaLive: OncoGenex increases economic interest in lead cancer drug OGX-011
Thursday, July 3rd, 2008VANCOUVER, July 3, 2008 /PRNewswire/ - OncoGenex Technologies Inc. and Isis Pharmaceuticals, Inc. announced today that the companies have amended their agreement and OncoGenex has elected to independently develop its lead cancer drug OGX-011. Under the amended agreement, OncoGenex is solely responsible for all future development activities, costs and partnering ...
PharmaLive: Senesco Signs a Supply Agreement for Polyplus-transfection’s Delivery System
Thursday, July 3rd, 2008NEW BRUNSWICK, N.J., July 03, 2008 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") announced today that it has contracted with Polyplus-transfection (Illkirch, France) to supply Polyplus's "in vivo-jetPEI" for systemic delivery of Senesco's combination therapy of siRNA against Factor 5A and a plasmid of the Factor 5A gene.Senesco ...
PharmaLive: Genedata and Axxam Announce High Throughput Screening Data Analysis Collaboration
Thursday, July 3rd, 2008BASEL, Switzerland and MILAN, Italy, July 3, 2008- Genedata and Axxam Announce High Throughput Screening Data Analysis Collaboration Genedata, the leading provider of in silico solutions for the pharmaceutical and life science industries, and Axxam, a leading biotechnology research organization offering early-stage discovery research services for the life science industry, have signed ...
PharmaLive: Senesco Chooses VGXI to Produce Factor 5A Plasmid
Thursday, July 3rd, 2008NEW BRUNSWICK, N.J., July 03, 2008 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") announced today that it has contracted with VGXI, Inc. (The Woodlands, TX) ("VGXI") to supply the plasmid portion of the Company's combination therapy consisting of the Factor 5A gene and siRNA against Factor 5A.Senesco has ...
PharmaLive: Adolor Provides Update on Entereg (alvimopan) OBD Program
Thursday, July 3rd, 2008EXTON, Pa.--(BUSINESS WIRE)--Jul 3, 2008 - Adolor Corporation (Nasdaq: ADLR) today issued an update on the Entereg(R) (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration with GlaxoSmithKline (NYSE: GSK). The U. S. Food and Drug Administration (FDA) has concluded that clinical investigations relating to alvimopan in ...